Literature DB >> 6697002

Erythrocyte pyruvate kinase deficiency: characterization of a new variant (PK "Aarau").

M Lakomek, H Winkler, M Scharnetzky, W Tillmann, G Laier, H R Marti, W Schröter.   

Abstract

A new PK variant with moderate hemolytic anemia is described. The enzymes of the nonanemic parents show sigmoidal reaction kinetics, with normal kinetic parameters, but differ with respect to nucleotide specificity, thermostability, and the concentrations of the glycolytic intermediates in the erythrocytes. The most characteristic features of the patient's (daughter) enzyme are a 30% activity, hyperbolic reaction kinetics and only two bands in the SDS-gel electrophoresis instead of three bands observed with the parental enzymes. Moreover, the pH-optimum is shifted to the acidic range, the affinity for PEP and ADP is decreased, ATP inhibition is negligible and FDP-activation is roughly ten times smaller than with controls. The concentrations of 2,3-DPG, 2-PG and PEP in the erythrocyte are increased, but ATP decreased. As there is no consanguinity in the parents and their enzymes are different this PK mutant can be considered to be compound-heterozygous for two different mutant PK alleles.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6697002     DOI: 10.1007/bf00320334

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  13 in total

1.  A specific erythrocyte glycolytic enzyme defect (pyruvate kinase) in three subjects with congenital non-spherocytic hemolytic anemia.

Authors:  W N VALENTINE; K R TANAKA; S MIWA
Journal:  Trans Assoc Am Physicians       Date:  1961

2.  Studies on erythrocyte glycolysis. I. Determination of the glycolytic intermediates in human erythrocytes.

Authors:  S Minakami; C Suzuki; T Saito; H Yoshikawa
Journal:  J Biochem       Date:  1965-12       Impact factor: 3.387

3.  A modified method for the determination of 2,3-diphosphoglycerate in erythrocytes.

Authors:  A Ericson; C H de Verdier
Journal:  Scand J Clin Lab Invest       Date:  1972-02       Impact factor: 1.713

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Recommended methods for the characterization of red cell pyruvate kinase variants. International Committee for Standardization in Haematology.

Authors: 
Journal:  Br J Haematol       Date:  1979-10       Impact factor: 6.998

6.  Pyruvate kinase "Göttingen 1,2": congenital hemolytic anemia, evidence of double heterozygosity, and lack of enzyme cooperativity.

Authors:  W Schröter; M Lakomek; M Scharnetzky; W Tillmann; H Winkler
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

7.  Hereditary pyruvate kinase deficiency: role of the abnormal enzyme in red cell pathophysiology.

Authors:  A Zanella; P Rebulla; C Vullo; C Izzo; F Tedesco; G Sirchia
Journal:  Br J Haematol       Date:  1978-12       Impact factor: 6.998

8.  The genetic system of the L-type pyruvate kinase forms in man. Subunit structure, interrelation and kinetic characteristics of the pyruvate kinase enzymes from erythrocytes and liver.

Authors:  A Kahn; J Marie; H Garreau; E D Sprengers
Journal:  Biochim Biophys Acta       Date:  1978-03-14

9.  Extreme deficiency of L-type pyruvate kinase with moderate clinical expression.

Authors:  G E Staal; G Rijksen; A M Vlug; B Vromen-van den Bos; J W Akkerman; G Gorter; J Dierick; M Petermans
Journal:  Clin Chim Acta       Date:  1982-02-05       Impact factor: 3.786

10.  Human erythrocyte pyruvate kinase. Total purification and evidence for its antigenic identity with L-type enzyme.

Authors:  J Marie; A Kahn; P Boivin
Journal:  Biochim Biophys Acta       Date:  1977-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.